Protein biopolymer markers indicative of alzheimer's disease
    41.
    发明授权
    Protein biopolymer markers indicative of alzheimer's disease 失效
    指示阿尔茨海默病的蛋白质生物聚合物标记物

    公开(公告)号:US07074576B2

    公开(公告)日:2006-07-11

    申请号:US09992672

    申请日:2001-11-23

    IPC分类号: G01N33/567 A61K38/00

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征与识别生物聚合物的存在和/或不存在相关的至少一种疾病状态的存在或不存在的能力,预测疾病风险评估以及开发针对该疾病的治疗途径。

    Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance
    42.
    发明申请
    Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance 审中-公开
    表示胰岛素抵抗的α型间胰蛋白酶抑制剂生物聚合物标记物

    公开(公告)号:US20060134699A1

    公开(公告)日:2006-06-22

    申请号:US11351461

    申请日:2006-02-10

    IPC分类号: G01N33/53 G01N33/00

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of at least one disease state relative to recognition of the presence and/or the absence of the biopolymer, predict disease risk assessment, and develop therapeutic avenues against the disease.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征与识别生物聚合物的存在和/或不存在相关的至少一种疾病状态的存在或不存在的能力,预测疾病风险评估以及开发针对该疾病的治疗途径。

    Apolipoprotein biopolymer marker indicative of normal human
    43.
    发明申请
    Apolipoprotein biopolymer marker indicative of normal human 失效
    代表正常人的载脂蛋白生物聚合物标记物

    公开(公告)号:US20060084112A1

    公开(公告)日:2006-04-20

    申请号:US09993300

    申请日:2001-11-23

    IPC分类号: G01N33/53

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer, predict disease risk assessment, and develop therapeutic avenues against said disease.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在的能力,以相对于识别所述生物聚合物的存在和/或不存在,预测疾病风险评估以及开发针对所述疾病的治疗途径。

    Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons
    44.
    发明申请
    Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons 失效
    指示分子量为1518道尔顿的疾病状态的生物聚合物标记物

    公开(公告)号:US20050287599A1

    公开(公告)日:2005-12-29

    申请号:US11144402

    申请日:2005-06-03

    CPC分类号: G01N33/6893

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在与识别所述生物聚合物的存在和/或不存在的能力。

    Ceiling fan display
    45.
    发明申请
    Ceiling fan display 失效
    吊扇显示

    公开(公告)号:US20050133675A1

    公开(公告)日:2005-06-23

    申请号:US10739080

    申请日:2003-12-19

    申请人: John Marshall

    发明人: John Marshall

    IPC分类号: A47F7/00 F16M13/00

    CPC分类号: A47F7/00

    摘要: The ceiling fan display comprises a stand having a vertical support with a horizontal support base extending from the bottom of the vertical support, and a horizontal support arm extending from the top of the vertical support. The ceiling fan is disposed at the distal end of the horizontal support arm. The horizontal support base is comprised of structural members that extend outward from the vertical support to form a “T” shaped outline. Boxes of the displayed ceiling fans may be stacked on the horizontal support base as a part of the sales display.

    摘要翻译: 吊扇显示器包括具有垂直支撑件的支架,其具有从垂直支撑件的底部延伸的水平支撑基座以及从垂直支撑件的顶部延伸的水平支撑臂。 吊扇设置在水平支撑臂的远端。 水平支撑基座由从垂直支撑件向外延伸以形成“T”形轮廓的结构构件组成。 显示的吊扇的盒可以作为销售显示的一部分堆叠在水平支撑基座上。

    Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons
    47.
    发明授权
    Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons 失效
    指示分子量为1,896道尔顿的疾病状态的生物聚合物标记物

    公开(公告)号:US06703366B2

    公开(公告)日:2004-03-09

    申请号:US09846343

    申请日:2001-04-30

    IPC分类号: A61K3800

    摘要: The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.

    摘要翻译: 本发明涉及使用组合的准备步骤与质谱法和飞行时间检测程序的组合,以使特定样品中可验证的生物聚合物的多样性最大化。 然后,在这样一个样本中验证的生物聚合物队列参照其证明至少一种特定疾病状态的能力; 从而使得诊断者能够获得表征所述至少一种疾病状态的存在或不存在与识别所述生物聚合物的存在和/或不存在的能力。